OSRH), a global healthcare company focused on advancing innovative therapies, today announced that it has entered into a Common Stock Purchase Agreement with White LionGBMInnovation Fund ("Innovation Fund") ... Innovate GBM ... About Innovate GBM.
HOUSTON, April 1, 2025 /PRNewswire/ -- Spanios is pleased to announce strategic partnership with GlioGuard aimed at propelling discovery and validation of groundbreaking therapeutic options for Glioblastoma (GBM) ... .
(MENAFN - InvestorBrandNetwork) CNSPharmaceuticals (NASDAQ. CNSP) a biopharmaceutical company targeting brain and CNS cancers, reported a full-year 2024 net loss of $14.9 million, down from $18.9 ... .